ArticleEuropean journal of cancer (Oxford, England : 1990)2017
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
Kilian Wistuba-Hamprecht et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it